{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T14:41:46Z","timestamp":1784385706419,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Oral mucositis (OM) is a common and significant complication of chemotherapy and radiotherapy, particularly in patients undergoing hematopoietic stem cell transplantation (HSCT). This retrospective observational study assessed the effectiveness of oral cryotherapy in reducing the incidence and severity of OM in 258 HSCT recipients treated at a single transplant center in Poland between 2018 and 2024. Patients were divided into two groups: 199 received cryotherapy as part of their conditioning regimen, while 59 did not. Cryotherapy was administered using ice chips from 10\u00a0min before chemotherapy infusion to two hours afterward. OM occurred in 48% of the cryotherapy group versus 68% in the control group, representing a statistically significant 20% relative risk reduction (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.008). Furthermore, the incidence of severe OM (grades 3\u20134) was significantly lower in the cryotherapy group (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.006). No significant differences were observed in platelet engraftment or hospitalization duration. Although neutrophil engraftment was slightly delayed in the cryotherapy group, this finding lacked clinical relevance. Overall, the results support cryotherapy as a safe, cost-effective, and easily implementable strategy for OM prevention in the HSCT setting. Further prospective studies are warranted to validate these findings and optimize treatment protocols.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-20927-5","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:35:49Z","timestamp":1761219349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of cryotherapy on incidence and severity of oral mucositis in hematopoietic stem cell transplantation: retrospective observational study"],"prefix":"10.1038","volume":"15","author":[{"given":"Oliwia","family":"Piotrowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Zuchma\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Kulig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Michowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Szulc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patryk","family":"Sk\u00f3rka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Dorsz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogus\u0142aw","family":"Machali\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Milczarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"20927_CR1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3109\/07357907.2014.919301","volume":"32","author":"K Arnaout","year":"2014","unstructured":"Arnaout, K. et al. Complications of allogeneic hematopoietic stem cell transplantation. Cancer Investig. 32, 349\u2013362 (2014).","journal-title":"Cancer Investig"},{"key":"20927_CR2","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1093\/rheumatology\/kead240","volume":"62","author":"Z Boyadzhieva","year":"2023","unstructured":"Boyadzhieva, Z., Ruffer, N., K\u00f6tter, I. & Krusche, M. How to treat VEXAS syndrome: a systematic review on effectiveness and safety of current treatment strategies. Rheumatology 62, 3518\u20133525 (2023).","journal-title":"Rheumatology"},{"key":"20927_CR3","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/cells11050843","volume":"11","author":"G Bagnato","year":"2022","unstructured":"Bagnato, G. et al. Autologous Haematopoietic stem cell transplantation and systemic sclerosis: focus on interstitial lung disease. Cells 11, 843 (2022).","journal-title":"Cells"},{"key":"20927_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.bbmt.2016.12.632","volume":"23","author":"E Maffini","year":"2017","unstructured":"Maffini, E. et al. Neurologic complications after allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transpl. 23, 388\u2013397 (2017).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"20927_CR5","doi-asserted-by":"publisher","unstructured":"Shimoni, A., Radici, V. & Nagler, A. Conditioning. in 125\u2013134 (2024). https:\/\/doi.org\/10.1007\/978-3-031-44080-9_13.","DOI":"10.1007\/978-3-031-44080-9_13"},{"key":"20927_CR6","first-page":"2019","volume":"18","author":"A Shankar","year":"2017","unstructured":"Shankar, A. et al. Current trends in management of oral mucositis in cancer treatment. Asian Pac. J. Cancer Prev. : APJCP. 18, 2019\u20132026 (2017).","journal-title":"Asian Pac. J. Cancer Prev. : APJCP"},{"key":"20927_CR7","doi-asserted-by":"publisher","first-page":"v119","DOI":"10.1093\/annonc\/mdw270","volume":"27","author":"F Roila","year":"2016","unstructured":"Roila, F. et al. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Ann. Oncol. 27, v119\u2013v133 (2016).","journal-title":"Ann. Oncol."},{"key":"20927_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/10428190400029957","volume":"46","author":"A Tartarone","year":"2005","unstructured":"Tartarone, A., Matera, R., Romano, G. & Vigliotti, M. L. Renzo, N. D. Prevention of high-dose melphalan-induced mucositis by cryotherapy. Leuk. Lymphoma. 46, 633\u2013634 (2005).","journal-title":"Leuk. Lymphoma"},{"key":"20927_CR9","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1200\/JCO.1999.17.8.2446","volume":"17","author":"AP Rapoport","year":"1999","unstructured":"Rapoport, A. P. et al. Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic Stem-Cell transplants. J. Clin. Oncol. 17, 2446\u20132446 (1999).","journal-title":"J. Clin. Oncol."},{"key":"20927_CR10","doi-asserted-by":"crossref","unstructured":"Haverman, T. M. et al. Oral Complications in Hematopoietic Stem Cell Recipients: The Role of Inflammation. Mediat. Inflamm. 378281 (2014).","DOI":"10.1155\/2014\/378281"},{"key":"20927_CR11","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.3390\/cancers15133295","volume":"15","author":"JM Reuss","year":"2023","unstructured":"Reuss, J. M. et al. Oral mucosa in cancer Patients\u2014Putting the pieces together: A narrative review and new perspectives. Cancers 15, 3295 (2023).","journal-title":"Cancers"},{"key":"20927_CR12","first-page":"804","volume":"33","author":"M Ali","year":"2023","unstructured":"Ali, M. et al. Oral mucositis in patients undergoing hematopoietic stem cell transplantation. J. Coll. Physicians Surg. Pak. 33, 804\u2013808 (2023).","journal-title":"J. Coll. Physicians Surg. Pak"},{"key":"20927_CR13","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00277-021-04568-y","volume":"100","author":"A Wysocka-S\u0142owik","year":"2021","unstructured":"Wysocka-S\u0142owik, A., Gil, L., \u015alebioda, Z., Kr\u0119gielczak, A. & Dorocka-Bobkowska, B. Oral mucositis in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation in relation to the conditioning used prior to transplantation. Ann. Hematol. 100, 2079\u20132086 (2021).","journal-title":"Ann. Hematol."},{"key":"20927_CR14","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1056\/NEJMoa040125","volume":"351","author":"R Spielberger","year":"2004","unstructured":"Spielberger, R. et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl. J. Med. 351, 2590\u20132598 (2004).","journal-title":"N Engl. J. Med."},{"key":"20927_CR15","first-page":"9141","volume":"30","author":"M Nakagaki","year":"2022","unstructured":"Nakagaki, M., Kennedy, G. A., Gavin, N. C., Clavarino, A. & Whitfield, K. The incidence of severe oral mucositis in patients undergoing different conditioning regimens in Haematopoietic stem cell transplantation. Support Care Cancer. 30, 9141\u20139149 (2022).","journal-title":"Support Care Cancer"},{"key":"20927_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/bmt.2010.184","volume":"46","author":"L Vagliano","year":"2011","unstructured":"Vagliano, L. et al. Incidence and severity of oral mucositis in patients undergoing Haematopoietic SCT\u2014results of a multicentre study. Bone Marrow Transpl. 46, 727\u2013732 (2011).","journal-title":"Bone Marrow Transpl."},{"key":"20927_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3324\/haematol.10232","volume":"92","author":"P Niscola","year":"2007","unstructured":"Niscola, P. et al. Mucositis in patients with hematologic malignancies: an overview. Haematologica 92, 222\u2013231 (2007).","journal-title":"Haematologica"},{"key":"20927_CR18","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1080\/14656566.2016.1217993","volume":"17","author":"A Villa","year":"2016","unstructured":"Villa, A. & Sonis, S. T. Pharmacotherapy for the management of cancer regimen-related oral mucositis. Expert Opin. Pharmacother. 17, 1801\u20131807 (2016).","journal-title":"Expert Opin. Pharmacother"},{"key":"20927_CR19","doi-asserted-by":"publisher","first-page":"102195","DOI":"10.1016\/j.esmoop.2023.102195","volume":"9","author":"J Herrstedt","year":"2024","unstructured":"Herrstedt, J. et al. 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting. ESMO Open. 9, 102195 (2024).","journal-title":"ESMO Open."},{"key":"20927_CR20","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1002\/cncr.33100","volume":"126","author":"S Elad","year":"2020","unstructured":"Elad, S. et al. MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 126, 4423\u20134431 (2020).","journal-title":"Cancer"},{"key":"20927_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/jop.12696","volume":"47","author":"J Walladbegi","year":"2018","unstructured":"Walladbegi, J. et al. Cooling of the oral mucosa to prevent adverse effects of chemotherapeutic agents: an in vitro study. J. Oral Pathol. Med. 47, 477\u2013483 (2018).","journal-title":"J. Oral Pathol. Med."},{"key":"20927_CR22","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1038\/s41409-019-0468-6","volume":"54","author":"JE Johansson","year":"2019","unstructured":"Johansson, J. E. et al. Cryotherapy as prophylaxis against oral mucositis after high-dose Melphalan and autologous stem cell transplantation for myeloma: a randomised, open-label, phase 3, non-inferiority trial. Bone Marrow Transpl. 54, 1482\u20131488 (2019).","journal-title":"Bone Marrow Transpl."},{"key":"20927_CR23","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1128\/MCB.22.15.5492-5505.2002","volume":"22","author":"S Braun","year":"2002","unstructured":"Braun, S. et al. Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol. Cell. Biol. 22, 5492\u20135505 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"20927_CR24","first-page":"519","volume":"14","author":"I von B\u00fcltzingsl\u00f6wen","year":"2006","unstructured":"von B\u00fcltzingsl\u00f6wen, I. et al. Growth factors and cytokines in the prevention and treatment of oral and Gastrointestinal mucositis. Support Care Cancer. 14, 519\u2013527 (2006).","journal-title":"Support Care Cancer"},{"key":"20927_CR25","doi-asserted-by":"publisher","DOI":"10.5114\/pm.2024.142027","author":"G Borowski","year":"2024","unstructured":"Borowski, G. et al. Oral mucositis \u2013 characteristics and management of a common complication of cancer treatment. Palliat. Med. https:\/\/doi.org\/10.5114\/pm.2024.142027 (2024).","journal-title":"Palliat. Med."},{"key":"20927_CR26","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1111\/j.1365-2702.2010.03255.x","volume":"19","author":"A Svanberg","year":"2010","unstructured":"Svanberg, A., \u00d6hrn, K. & Birgeg\u00e5rd, G. Oral cryotherapy reduces mucositis and improves nutrition \u2013 a randomised controlled trial. J. Clin. Nurs. 19, 2146\u20132151 (2010).","journal-title":"J. Clin. Nurs."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20927-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20927-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20927-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:35:51Z","timestamp":1761219351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20927-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20927"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20927-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6813382\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37066"}}